/Zoetis%20Inc%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $84.2 billion, Zoetis’ operations span over 100 countries in North America, Europe, and internationally.
Shares of the animal health firm have substantially underperformed the broader market over the past year. Over the past 52 weeks, ZTS surged 1.1% compared to the S&P 500 Index's ($SPX) 28.1% returns. In 2024, ZTS declined 7%, while SPX returned 17.3% on a YTD basis.